Kirsten Drejer
Fortuna: 561 529 $ al 30/06/2026
Fortuna: 561 529 $ al 30/06/2026
Kirsten Aarup Drejer was the founder of Servier Symphogen A, founded in 2000, and served as Chief Executive Officer from 2000 to 2016.
Current jobs include Vice Chairman at Zealand Pharma A since 2019, Chairman at Curasight A since 2024, Chairman at Bioneer A since 2017, Chairman at ResoTher Pharma AS since 2018, and Director at Lyhne & Co. Former jobs include Director at International N&H Denmark ApS from 2006 to 2011, Independent Director at Bioporto A from 2017 to 2021, Independent Director at Alligator Bioscience AB from 2019 to 2021, Director at DTU Systems Biology, Independent Non-Executive Director at Bionor Pharma ASA from 2015 to 2016, Director at The Danish Green Growth Fund, Independent Non-Executive Director at Malin Corp.
Plc from 2020 to 2026, Director-Diabetes Discovery at Novo Nordisk A from 1992 to 2000, Director at The Danish National Advanced Technology Foundation from 2010 to 2012, Director at Antag Therapeutics ApS, and Professor at the University of Copenhagen.
Education includes graduate and doctorate degrees from Danmarks Farmaceutiske Universitet.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,02 % | 31/12/2025 | 12.177 ( 0,02 % ) | 539 379 $ | 30/06/2026 |
CURASIGHT A/S 0,01 % | 30/06/2025 | 6.929 ( 0,01 % ) | 22 150 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ZEALAND PHARMA A/S | Director/Miembro de la Junta | 19/04/2018 |
| CURASIGHT A/S | Presidente | 01/01/2024 |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Presidente | 01/04/2017 |
Lyhne & Co. | Director/Miembro de la Junta | - |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Presidente | 10/07/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| MALIN CORPORATION PLC | Director/Miembro de la Junta | 26/03/2026 |
The Danish Green Growth Fund
The Danish Green Growth Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Miembro de la Junta | 02/01/2023 |
| ALLIGATOR BIOSCIENCE AB | Director/Miembro de la Junta | 01/06/2021 |
| BIOPORTO A/S | Director/Miembro de la Junta | 29/04/2021 |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 18 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Malin Corp. Plc
Malin Corp. Plc BiotechnologyHealth Technology Provides life science services | Health Technology |
International N&H Denmark ApS
International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables Produces food enzymes, products and pharmaceutical grade excipients for food products | Consumer Non-Durables |
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
Alligator Bioscience AB
Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danmarks Farmaceutiske Universitet
Danmarks Farmaceutiske Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
DTU Systems Biology | |
The Danish National Advanced Technology Foundation
The Danish National Advanced Technology Foundation Financial ConglomeratesFinance Promotes research and innovation by providing funds | Finance |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Curasight A/S
Curasight A/S Medical SpecialtiesHealth Technology Provides PET imaging research techniques for prostate cancer | Health Technology |
The Danish Green Growth Fund
The Danish Green Growth Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Antag Therapeutics ApS
Antag Therapeutics ApS Medical/Nursing ServicesHealth Services Provides obesity, diabetes and overweight therapy services | Health Services |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Health Technology |
Lyhne & Co. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.